This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Apr 3;452(7187):543-5.

doi: 10.1038/452543a.

RNA interference: generic block on angiogenesis

Raghu Kalluri, Keizo Kanasaki

PMID: 18385725
DOI: 10.1038/452543a

Comment

RNA interference: generic block on angiogenesis

Raghu Kalluri et al. Nature. 2008.

. 2008 Apr 3;452(7187):543-5.

doi: 10.1038/452543a.

Authors

Raghu Kalluri, Keizo Kanasaki

PMID: 18385725
DOI: 10.1038/452543a

No abstract available

PubMed Disclaimer

Comment on

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.
Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y, Appukuttan B, Gibbs D, Yang Z, Karikó K, Ambati BK, Wilgus TA, DiPietro LA, Sakurai E, Zhang K, Smith JR, Taylor EW, Ambati J. Kleinman ME, et al. Nature. 2008 Apr 3;452(7187):591-7. doi: 10.1038/nature06765. Epub 2008 Mar 26. Nature. 2008. PMID: 18368052 Free PMC article.

Similar articles

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.
Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y, Appukuttan B, Gibbs D, Yang Z, Karikó K, Ambati BK, Wilgus TA, DiPietro LA, Sakurai E, Zhang K, Smith JR, Taylor EW, Ambati J. Kleinman ME, et al. Nature. 2008 Apr 3;452(7187):591-7. doi: 10.1038/nature06765. Epub 2008 Mar 26. Nature. 2008. PMID: 18368052 Free PMC article.
[Unspecific effects of certain siRNA molecules used in the treatment of age related macular degeneration].
Ebbesen M, Bek T, Pedersen FS, Jensen TG. Ebbesen M, et al. Ugeskr Laeger. 2010 Sep 6;172(36):2457-9. Ugeskr Laeger. 2010. PMID: 20825735 Danish.
Wandering eye for RNAi.
Rossi J, Zamore P, Kay MA. Rossi J, et al. Nat Med. 2008 Jun;14(6):611. doi: 10.1038/nm0608-611. Nat Med. 2008. PMID: 18535575 No abstract available.
Short interfering RNA (siRNA), a novel therapeutic tool acting on angiogenesis.
Hadj-Slimane R, Lepelletier Y, Lopez N, Garbay C, Raynaud F. Hadj-Slimane R, et al. Biochimie. 2007 Oct;89(10):1234-44. doi: 10.1016/j.biochi.2007.06.012. Epub 2007 Jul 6. Biochimie. 2007. PMID: 17707573 Review.
Vascular endothelial growth factor targeted RNA interference as a modulator of angiogenesis.
Celec P, Yonemitsu Y. Celec P, et al. Biomed Pharmacother. 2008 Jul-Aug;62(6):349-51. doi: 10.1016/j.biopha.2008.01.014. Epub 2008 Feb 20. Biomed Pharmacother. 2008. PMID: 18406102 Review.

See all similar articles

Cited by

Transplantation of IL-1β siRNA-modified bone marrow mesenchymal stem cells ameliorates type II collagen-induced rheumatoid arthritis in rats.
Pan S, Dong X, Wang Y, Zhou T, Liu Y, Zhou A, Xing H. Pan S, et al. Exp Ther Med. 2022 Feb;23(2):139. doi: 10.3892/etm.2021.11062. Epub 2021 Dec 14. Exp Ther Med. 2022. PMID: 35069820 Free PMC article.
PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts.
Deharvengt SJ, Tse D, Sideleva O, McGarry C, Gunn JR, Longnecker DS, Carriere C, Stan RV. Deharvengt SJ, et al. J Cell Mol Med. 2012 Nov;16(11):2690-700. doi: 10.1111/j.1582-4934.2012.01587.x. J Cell Mol Med. 2012. PMID: 22568538 Free PMC article.
Novel drugs and their targets in the potential treatment of diabetic retinopathy.
Nawaz MI, Abouammoh M, Khan HA, Alhomida AS, Alfaran MF, Ola MS. Nawaz MI, et al. Med Sci Monit. 2013 Apr 26;19:300-8. doi: 10.12659/MSM.883895. Med Sci Monit. 2013. PMID: 23619778 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database